Precision BioSciences (NASDAQ:DTIL) reported quarterly losses of $(2.13) per share which missed the analyst consensus estimate of $(1.57) by 35.93 percent. This is a 145.61 percent decrease over earnings of $4.67 per share from the same period last year. The company reported quarterly sales of $18.00 thousand which missed the analyst consensus estimate of $6.27 million by 99.71 percent. This is a 99.96 percent decrease over sales of $49.90 million the same period last year.